Literature DB >> 6891332

Radiation and drug response of the rat glioma RG2.

M Weizsäcker, A Nagamune, R Winkelströter, H Vieten, W Wechsler.   

Abstract

A clonogenic cell assay was developed for the chemically induced rat glioma RG2 that allows in vivo, in vitro, and in vivo to in vitro studies of cell survival after experimental therapy. RG2 monolayer cells were resistant to BCNU up to high concentrations. The radiation survival curves were characterized by a Do of 2.4 gray and n = 2.2 for monolayer cells, a Do of 3.5 gray and n = 1.3 for cells irradiated as brain tumors in air-breathing rats, and a Do of 5.9 gray and n = 1.2 for cells irradiated as brain tumors in nitrogen-asphyxiated rats. There was no evidence of a radiobiologically hypoxic fraction of cells in the brain tumors, but their radiosensitivity was definitely smaller than that of monolayer cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891332     DOI: 10.1016/0277-5379(82)90200-0

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  7 in total

Review 1.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

2.  Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model.

Authors:  Yohei Mineharu; A K M Ghulam Muhammad; Kader Yagiz; Marianela Candolfi; Kurt M Kroeger; Weidong Xiong; Mariana Puntel; Chunyan Liu; Eva Levy; Claudia Lugo; Adrina Kocharian; James P Allison; Michael A Curran; Pedro R Lowenstein; Maria G Castro
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

3.  The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma.

Authors:  Andreas Jordan; Regina Scholz; Klaus Maier-Hauff; Frank K H van Landeghem; Norbert Waldoefner; Ulf Teichgraeber; Jens Pinkernelle; Harald Bruhn; Fabian Neumann; Burghard Thiesen; Andreas von Deimling; Roland Felix
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

4.  Brain tumor growth and response to chemotherapy in the subrenal capsule assay.

Authors:  M Weizsäcker; A Nagamune; K Rathmer; W Wechsler
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  A reproducible model of intramedullary spinal cord tumor in rats bearing RG2 cells.

Authors:  Yuandong Zhuang; Wei Zhao; Weiqiang Zhang; Hao Wei; Xinming Huang; Gangfeng Cai; Chaofeng Fu; Chunhua Wang; Rui Wang; Songsheng Shi; Weizhong Yang; Chunmei Chen
Journal:  Oncotarget       Date:  2017-05-09

6.  Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma.

Authors:  Arthur Chakwizira; Jonatan Ahlstedt; Henrietta Nittby Redebrandt; Crister Ceberg
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

Review 7.  Glioblastoma Treatments: An Account of Recent Industrial Developments.

Authors:  Edouard Alphandéry
Journal:  Front Pharmacol       Date:  2018-09-13       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.